# Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks

> **NCT02904213** · NA · COMPLETED · sponsor: **Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products** · enrollment: 330 (actual)

## Conditions studied

- Safety, Pentavalent Vaccine

## Interventions

- **BIOLOGICAL:** ComBe Five (Liquid)

## Key facts

- **NCT ID:** NCT02904213
- **Lead sponsor:** Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-16
- **Primary completion:** 2016-12-19
- **Final completion:** 2017-06-24
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2017-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904213, "Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02904213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*